EssilorLuxottica (OTCMKTS:ESLOY) Sees Unusually-High Trading Volume – Here’s What Happened

EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY – Get Free Report) shares saw strong trading volume on Tuesday . Approximately 64,803 shares were traded during mid-day trading, a decline of 48% from the previous session’s volume of 123,702 shares.The stock last traded at $92.77 and had previously closed at $92.8350.

Analyst Ratings Changes

ESLOY has been the subject of a number of research reports. The Goldman Sachs Group cut EssilorLuxottica from a “buy” rating to a “hold” rating in a research report on Tuesday, July 14th. Zacks Research upgraded EssilorLuxottica from a “strong sell” rating to a “hold” rating in a research note on Tuesday, August 18th. Finally, Deutsche Bank Aktiengesellschaft began coverage on EssilorLuxottica in a report on Tuesday, May 12th. They set a “hold” rating for the company. Two research analysts have rated the stock with a Strong Buy rating, four have given a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy”.

Get EssilorLuxottica alerts:

Get Our Latest Stock Report on ESLOY

EssilorLuxottica Price Performance

The company has a current ratio of 0.99, a quick ratio of 0.70 and a debt-to-equity ratio of 0.17. The company’s fifty day moving average is $95.73 and its 200-day moving average is $108.04.

About EssilorLuxottica

(Get Free Report)

EssilorLuxottica SE is a global ophthalmic optics company formed through the 2018 merger of France-based Essilor and Italy-based Luxottica. Headquartered near Paris, the company combines lens manufacturing, frame design and production, brand management and retail operations to provide a vertically integrated offering across the vision care value chain. Its activities span product research and development, manufacturing, wholesale distribution and retailing of spectacles, sunglasses and ophthalmic lenses.

The company’s product portfolio includes prescription and non-prescription lenses, lens coatings and treatments, and an array of eyewear brands and frames.

Read More

• Five stocks we like better than EssilorLuxottica
• NVIDIA’s MediaTek Bet Shows How It Plans to Defend Its AI Moat
• Is Abercrombie & Fitch’s Hot Streak Just Getting Started?
• Medtronic’s Stars Are Aligning for a Price Recovery
• Analysts See Major Upside for This Top-10 Performing S&P 500 Stock

Receive News & Ratings for EssilorLuxottica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EssilorLuxottica and related companies with MarketBeat.com's FREE daily email newsletter.